Injective (INJ) was trading at $7.97 on October 23, 2026, down 1.51% over 24 hours, as its MACD histogram reached exactly zero and Binance futures open interest expanded 21% to $31.78 million — a c...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

INJ posted a 1.51% decline over the 24 hours to October 23, 2026, settling at $7.97 within a $7.85–$8.33 daily range on Binance spot. That price occupies a technically uncomfortable position: below the 7-day SMA ($8.48) and the 12-period EMA ($8.23), which together act as near-term resistance, yet above the 50-day SMA ($7.25) and the 200-day SMA ($5.32). The medium- and longer-term moving average structure remains constructive, but the short-term averages have flipped into headwinds. The 26-period EMA at $7.90 is the one exponential anchor INJ is still holding above, preventing a clean bearish alignment across all time horizons.

The most consequential reading from the supplied technical data is the MACD histogram, which has reached exactly 0.0000 — the MACD line (0.3296) and its signal line (0.3296) have fully converged. This is the crossover juncture: the next daily print either confirms a fresh bullish cross or marks a rollover. The flat histogram is a setup, not a signal; momentum is suspended rather than committed in either direction.

08 reinforces that suspension — neutral by any standard measure, with no overbought or oversold distortion at work. 32), a configuration that can precede recovery from mid-range territory, though both readings remain in the lower half of their scale and fall short of confirmation on their own.

Source link